Efficiency of the intravenous laser therapy in metabolic disorders correction

Abstract

Despite the wide range of medicines which are used for the treatment of any disease, today increasing attention is paid to physiotherapy methods, namely the method of the intravenous laser therapy (ILT) which has been successfully used for the last 30 years in almost all areas of medicine. To estimate the effectiveness of ILT in the treatment of patients with hypothyroidism combined with nonalcoholic fatty liver disease (NAFLD) 180 people with dyslipidemia were examined. The 1st group included 60 patients who didn’t have any complaints but had dyslipidemia. The 2nd group included 60 patients with NAFLD, the 3rd group included 60 patients with hypothyroidism combined with NAFLD. Based on the genetic research of polymorphic variants of the CYP7A1 gene, patients were divided into the following subgroups: 1 AA – 52 patients, 1 CC – 8 patients; 2 AA – 50 patients, 2 CC – 10 patients; 3 AA – 48 patients, 3 CC – 12 patients. Treatment was provided with Omega-3 Acid Ethyl Esters and ILT with laser wavelength λ=635 nm and laser power equals to 1,5 mW. The most pronounced effect was achieved in 2 CC and 3 CC groups due to reducing of TC, LDL, TG and the Atherogenic Index. Patients of 2 AA and 3 AA groups had statistically significant dynamics of HDL increasing. The dynamics of normalization of cytolysis syndrome indices didn’t have genetically determined differences and prevailed in the 2nd group compared to the 3rd group in which the presence of hormonal imbalance delayed the activation of reparative mechanisms of damaged liver cells.